New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs for millions of people.

The Semaglutide market is projected to expand from US$ 27.15 billion in 2024 to US$ 61.7 billion by 2033, with a CAGR of 9.55% from 2025. Driven by rising obesity and type 2 diabetes incidences, the ...

Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...

The conversation around Semaglutide, known widely by brand names like Ozempic and Wegovy, has undeniably captured global ...

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...

You’ve probably heard of the semaglutide brand names Ozempic®, Wegovy, and Rybelsus. You may have even heard about affordable options like compounded semaglutide.

Due to popularity of the medications, GLP-1s were in short supply up until recently. Obesity is a common issue among ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Diabetes drug semaglutide linked to reduced risk of dementia in type 2 diabetes patients Effects strongest in women and older ...

Patients have been referred to hospital emergency departments after mistakenly overdosing on diabetes drugs such as Ozempic, ...

Amanda Bynes revealed her decision to start Ozempic to lose more than 40 pounds, improve her health and feel confident in paparazzi photos ...